Network pharmacology combined with untargeted metabolomics reveals the intervention mechanism and compatibility of chenpi-rougui herb pair in nonalcoholic fatty liver disease
These results provided valuable insights into the compatibility mechanism of CRP for treating NAFLD, and could also improve the value of its forthcoming application and development as a natural liver protective agent.
Authors
- Huiwen Yao
- Jinlin Xu (ORCID: https://orcid.org/0000-0001-5803-9029)
- Shan Cao (ORCID: https://orcid.org/0000-0002-5185-3965)
- Yuehui Jin (ORCID: https://orcid.org/0000-0003-3961-2832)
- Sen Li (ORCID: https://orcid.org/0000-0003-3297-6270)
- Xu Hu (ORCID: https://orcid.org/0000-0001-6448-4073)
- Huimin Zhou (ORCID: https://orcid.org/0009-0006-3266-8779)
Institutions
- Union Hospital (HK)
- Hubei University of Chinese Medicine (CN)
- Ezhou Central Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Molecular Biosciences
- Published
- 2025-03-13
- DOI
- https://doi.org/10.3389/fmolb.2025.1553162
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35